Mirum Pharmaceuticals Inc (MIRM)
25.89
+0.29
(+1.13%)
USD |
NASDAQ |
May 03, 15:24
Mirum Pharmaceuticals Accounts Payable (Quarterly): 7.416M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.416M |
September 30, 2023 | 7.369M |
June 30, 2023 | 14.45M |
March 31, 2023 | 6.44M |
December 31, 2022 | 8.69M |
September 30, 2022 | 10.55M |
June 30, 2022 | 8.119M |
March 31, 2022 | 4.943M |
December 31, 2021 | 9.166M |
September 30, 2021 | 5.003M |
Date | Value |
---|---|
June 30, 2021 | 5.38M |
March 31, 2021 | 5.658M |
December 31, 2020 | 3.151M |
September 30, 2020 | 5.177M |
June 30, 2020 | 3.024M |
March 31, 2020 | 3.265M |
December 31, 2019 | 3.351M |
September 30, 2019 | 2.665M |
June 30, 2019 | 2.348M |
March 31, 2019 | 2.375M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.348M
Minimum
Jun 2019
14.45M
Maximum
Jun 2023
6.114M
Average
5.38M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Gilead Sciences Inc | 550.00M |
Vanda Pharmaceuticals Inc | 7.145M |
Sarepta Therapeutics Inc | 91.54M |
Puma Biotechnology Inc | 6.889M |
Reneo Pharmaceuticals Inc | 8.717M |